Previous work demonstrated that relatively high concentrations of jasplakinolide do not inhibit growth of wildtype yeast cells, nor does the drug affect actin structures, as determined by rhodamine-phalloidin staining [1] . Here, the effects of jasplakinolide were analysed in a Saccharomyces cerevisiae strain in which two multidrug resistance ABC-transporter genes (PDR5 and SNQ2) were deleted from the genome. While this strain is sensitive to a range of drugs, it is morphologically the same as wild-type yeast cells and rhodamine-phalloidin staining indicates that its actin cytoskeleton is organised appropriately (K.R.A., unpublished data). Sensitivity to jasplakinolide was assessed as detailed in the Supplementary material. The lowest concentration of jasplakinolide at which effects on growth were observed (10 µM) was then used to analyse the effects of the drug on the actin structures within cells.
Using rhodamine-phalloidin to stain F-actin structures, a rapid and dramatic alteration in the actin cytoskeleton of jasplakinolide-treated cells was observed. Rather than many small cortical patches, a single large clump of actin was present (Figure 1a,b) . The staining obtained with rhodamine-phalloidin was considerably weaker than is normally seen for F-actin structures in yeast, however, and actin cable structures were not observed at all. This supports previous in vitro reports which indicate competitive binding of jasplakinolide and rhodamine-phalloidin [5] . Treating cells with jasplakinolide for 10 minutes, then washing the cells, releasing into fresh medium and immediately taking a sample for rhodamine-phalloidin staining then revealed a single, but bright aggregate of F-actin staining and actin cables could be visualised, demonstrating release of jasplakinolide and renewed access for rhodamine-phalloidin (Figure 1c ). This competition in F-actin binding suggests a site for jasplakinolide binding overlapping that for phalloidin, which has been mapped to the crux of three actin monomers within the filament [7, 8] .
To assess whether the actin clumps represented dynamic or static F-actin structures within the cell, another drug, latrunculin-A (LAT-A), was used. Previous studies demonstrated that LAT-A is a rapid and reversible inhibitor of actin polymerisation that acts by association with the actin monomer, thus preventing its reincorporation into filaments [1, 9] . If actin in jasplakinolide-induced structures is dynamic, the monomer will be released and could be sequestered by LAT-A, leading to the steady dispersal of the aggregates. If, however, jasplakinolide stabilises the structures such that the actin is not dynamic, then the aggregates will persist in the presence of LAT-A. The jasplakinolide-sensitive yeast were assessed for LAT-A sensitivity and 10 µM LAT-A was found to cause > 98% of actin structures to disassemble after 15 minutes incubation, a similar degree of effect compared with incubation of wild-type strains with 200 µM LAT-A (data not shown) [1] .
Approaches, using both fixed and live cells, were used to study the effects of jasplakinolide and LAT-A treatment. For live-cell studies, yeast were transformed with a plasmid expressing green fluorescent protein (GFP)-tagged Abp1p. Abp1p is a protein that binds directly to actin and colocalises with cortical actin patches [10] . Similar results were obtained with both live and fixed cells but only those obtained with the Abp1-GFP are reported here. To investigate whether F-actin clumps were dynamic, Abp1-GFP-expressing cells were incubated with jasplakinolide for 10 minutes when over 90% of actin was observed to be reorganised from multiple cortical patches (Figure 1d ) into one or two clumps in cells (Figure 1e ). LAT-A was then added at various concentrations either equal to (10 µM), or up to 5 times, that of jasplakinolide. The effects on the actin clumps over time points up to 8 hours were monitored. Over this time course, no dispersal of the aggregates was observed at any concentration of LAT-A, indicating that the aggregates are extremely stable structures and suggesting that monomeric actin is not released and made available for LAT-A binding (Figure 1f ).
Possible mechanisms for formation of actin clumps could be that either the monomer is released from existing patches and then stably incorporated into an increasingly large jasplakinolide-stabilised clump, or that existing patches can coalesce and fuse to form large clumps. Timelapse images taken at 20 second intervals demonstrated the movement and fusion of existing clumps rather than one patch growing as other patches depolymerise with their actin being reincorporated into the single clump (see Figure 1g and the video in Supplementary material). Furthermore, the continued movement of cortical patches as they reorganise into the jasplakinolide-induced clump supports the idea that actin dynamics are not required for actin-patch movement in yeast [11, 12] .
To ascertain whether the actin in these large clumps was structurally affected or similar to that in untreated cells, we performed double-labelling immunofluorescence with antibodies against actin and several components that normally associate with cortical F-actin patches: Arp2, Abp1 and cofilin [10, 13, 14] , and Sac6p which associates with both patch and cable structures [10] . Following jasplakinolide treatment, all four components were seen to colocalise with the large clumps of F-actin, providing convincing evidence that the actin within the patches is filamentous rather than monomeric (Figure 2) . Furthermore, the large actin structures were also unlikely to represent aberrantly polymerised F-actin aggregates or precipitates as several protein-binding sites were preserved. Furthermore, when using antibodies to visualise actin rather than rhodamine-phalloidin, actin cables in cells in the presence of jasplakinolide were seen. Sac6p colocalised with actin in these structures, demonstrating that both actin patch and 1588 Current Biology Vol 10 No 24
Figure 2
The actin clumps induced by jasplakinolide contain proteins normally associated with cortical actin patches. Cells in exponential growth phase were treated for 30 min with 10 µM jasplakinolide, then fixed and processed for immunofluorescence as described in the Supplementary material. Double labelling was performed using antibodies against yeast actin and In studies of motile mammalian cells, at early time points after drug addition, F-actin stabilisation effects similar to those observed here have been reported but, at later times, a dramatic increase in F-actin levels is observed, presumably because of mobilisation of actin from sequestered monomer pools and its incorporation into filaments [4] . Thus, with prolonged incubation, it is difficult to determine whether the effects observed are due to actin stabilisation or because cells contain more F-actin. In yeast, nearly all actin is in the F-actin form and there is very little 'reserve' of G-actin available for such bursts of polymerisation (G-actin has been measured as about 0.015 ng/µg of total cell protein with total actin being measured as about 1.5 ng/µg total protein -thus G-actin represents only about 1% of yeast cell actin [15, 16] ). An increase in level of F-actin is therefore unlikely on addition of jasplakinolide to yeast, and changes observed will be due to an increase in F-actin stabilisation.
Having established that jasplakinolide abrogates F-actin dynamics in yeast, mechanisms requiring an intact actin cytoskeleton were investigated to assess whether they also require the actin to be dynamic. It was determined whether, in the presence of jasplakinolide, a population of unbudded cells could form a bud and whether they could localise the polarity marker Cdc42p. In yeast, Cdc42p localises as a single patch at the presumptive site of bud formation and to the tip of growing buds [17] and is required for the generation of cell polarity [18] . In the untreated cells, budding was observed after 2 hours and Cdc42p became localised to a patch at the bud site and to the tip of the growing bud (Figure 3a,b) . At 4 hours, over 75% of cells showed polarised staining of Cdc42p. In the presence of jasplakinolide cells did not bud, nor did Cdc42p become localised (Figure 3c,d ), indicating the importance for cellular F-actin to be dynamic for the establishment of cell polarity.
Actin is also critical for endocytosis in yeast, and treatment of cells with LAT-A, which depolymerises the actin cytoskeleton, completely blocks uptake of the fluid-phase marker lucifer yellow (LY) [1] . In the absence of jasplakinolide, uptake of LY into vacuoles could be clearly seen (Figure 4a ). In jasplakinolide-treated cells, uptake was severely abrogated, though very low levels of fluorescence in the vacuoles could still be observed (Figure 4b) . A particularly interesting observation was that, in jasplakinolide-treated cells, rather than LY staining being observed uniformly over the cell surface as observed in studies when actin is disrupted in yeast cells [11, 12, 19, 20] , there appeared to be discrete spots of staining at the cell cortex, suggesting that endocytosis is stalled at a specific stage in the uptake process. This previously unreported observation of bright punctate staining at the cortex suggests a hitherto uncharacterised requirement for F-actin at a specific stage in the endocytic process, and future studies will aim to characterise in more detail the stage at which endocytosis is blocked following F-actin stabilisation. A similar 'single actin-clump' phenotype is observed in cells in which genes for the actin-regulating kinases Ark1p and Prk1p are deleted [21] . It will be of interest to ascertain whether these kinases are directly involved in regulation of actin dynamics and have effects on endocytosis similar to those observed following jasplakinolide treatment.
The studies presented here demonstrate that the actinstabilising drug jasplakinolide can dramatically affect the actin cytoskeleton in S. cerevisiae. The structures formed appeared to be structurally similar to normal F-actin structures in yeast but were no longer dynamic. Use of jasplakinolide has made it possible to address the question of the Brief Communication 1589 requirement for actin in yeast to be dynamic and demonstrate that this property is essential for the fundamental processes of polarity establishment and endocytosis, but is not necessary for movement of cortical actin.
Supplementary material
Additional methodological detail, a movie showing cells expressing Abp1-GFP in the presence and absence of jasplakinolide, and a figure showing the assay used to determine the sensitivity of strains to jasplakinolide is available at http://current-biology.com/supmat/supmatin.htm.
Figure 4
Fluid-phase endocytosis requires the presence of dynamic F-actin. Fluid-phase endocytosis was assessed by uptake of LY (see Supplementary material). Cells were either (a) untreated or (b) incubated in the presence of 10 µM jasplakinolide for 10 min prior to addition of LY and then throughout the 2 h incubation with the stain. To allow comparison of uptake, the time of exposure for image recording was the same in each case. The scale bar represents 10 µm.
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